2 paths to success on the medtech fundraising trail

Funding a medical technology company isn’t a simple job: Modern medical devices require cutting-edge innovation, research and design to make it to market. And don’t even get started on regulatory and reimbursement challenges. The recession of the late 2000s, Affordable Care Act and changes to regulatory bodies and reimbursement requirements have changed the game for

Pages: 1 2 3

Spectrum Plastics Group: Why the merger took place

The M&A deal creating Spectrum Plastics Group is but the latest in a wave of consolidations taking place among medical device industry outsourcers. Mauricio Arellano, president of Spectrum’s medical division, thinks 2 trends are driving the consolidations: the need of OEMs to provide truly disruptive innovations to meet health providers needs for value-based care, and

5 officials running healthcare under Trump

President Donald Trump’s critics complain that the president has yet to make hundreds of appointments to midlevel positions. But at least with healthcare, we’re starting to get a clearer picture of who is in charge. Just on May 10, the U.S. Senate confirmed Dr. Scott Gottlieb as FDA commissioner. Here are 5 top officials shaping

Pages: 1 2 3 4 5 6

North American artificial disc replacement market to reach $614.5 million

The North American artificial disc replacement (ADR) market – which covers Canada, Mexico and the U.S. – is set to more than double from $274.6 million in 2016 to around $614.5 million by 2023, representing a compound annual growth rate of 12.2%, according to research and consulting firm GlobalData. The company’s latest report states that key

Stratasys revenue down 3% in Q1

3D printing and additive manufacturing company Stratasys said today that its first-quarter revenue was down 3% year-over-year, to $163.2 million – even as consumable revenue increased 7%. Losses narrowed to $13.9 million, or 26 cents per share, from a loss of $23.1 million, or 44 cents per share a year before. Stratasys officials, however, think results

AdvaMed unveils new tools to assess medical device value

AdvaMed today launched a new value initiative that includes extensive tables of questions to help medical device companies formulate value-based arguments. The value framework also includes tools specifically designed for diagnostic technologies, as well as report on understanding evidence and use cases. “Value” has become an important word in medtech in recent years as government and

Micron Solutions boosts revenues, narrows losses in Q1

Precision medical device components maker Micron Solutions reported improvements with its finances during the first three months of 2017–even as it faced challenges related to validation requirements. “We have made several improvements in quality systems, capacity and our ability to meet customer requirements. We believe we have laid a solid foundation for further improvement and

Endra Life Sciences IPO to raise $8.4 million

Endra Life Sciences’s IPO offering, which closes tomorrow, is expected to raise $8.4 million as the company seeks to commercialize its Thermo Acoustic Enhanced Ultrasound (TAEUS) in Europe. Endra announced May 9 that the IPO would involve 1.68 million units – each including one share of common stock and a warrant to purchase an additional share of

Avinger shares dive on Q1 miss

Shares in Avinger have fallen over 15% today after the medical device maker missed expectations on Wall Street with its 1st quarter earnings results. The Redwood City, Calif.-based company posted losses of $15.3 million, or 64¢ per share, on sales of $3.5 million for the 3 months ended March 31, seeing losses shrink 5.1% while

Integer Holdings schedules Q1 earnings release for May 8

Integer Holdings (NYSE:ITGR)  said last week it will release its 1st quarter earnings on May 8th, scheduled to be released after the market closes. The release will be followed by a conference call with the management of the company, according to a press release. Read the whole story on our sister site, MassDevice.com

Tandem misses on Q1 earnings, beats rev estimates

Shares in Tandem Diabetes (NSDQ:TNDM) fell today after the medical device maker missed earnings expectations on Wall Street with its 1st quarter results, but beat revenue estimates. The San Diego-based company posted losses of -$23.8 million, or -75¢ per share, on sales of $18.9 million for the 3 months ended March 31, for bottom-line loss of -13.9%

Integra shares down on Q1 release

Updated to correct company – previously identified Integer Holdings. Shares in Integra LifeSciences (NSDQ:IART) dippes lightly today after the medical device maker posted 1st quarter earnings that met expectations on Wall Street. The Plainsboro, N.J.-based company posted profits of $6.4 million, or 8¢ per share, on sales of $258.6 million for the 3 months ended March 31, for

Underwriters Laboratories acquires Emergo Group

Global safety science company Underwriters Laboratories (UL) has acquired Emergo, a privately held firm that provides regulatory services and market access services to medical device manufacturers. The financial details of the acquisition were not disclosed. The acquisition, announced yesterday, combines UL’s range of services to support global regulatory approvals for the health sciences industry with

The 10 hottest medtech startups of 2017

Medtech startups face more challenges than they have in the past, but several companies are developing products that take advantage of new technology and are specifically designed to meet healthcare’s evolving needs.    The number of medtech startups has declined. Thirty years ago, the medtech field averaged 1,500 startups; it slid to about 600 by

Pages: 1 2 3 4 5 6 7 8 9 10 11

These big medtech names performed the best in early 2017

Fink Densford, Associate Editor and Chris Newmarker, Managing Editor This year so far has been an especially good one for medical device company stocks. More than four-fifths of the world’s 100 largest medical device companies saw their stock values increase during the first quarter of 2017 – about half enjoyed double-digit percentage increases, according to an analysis

Pages: 1 2 3 4 5 6 7 8